https://www.selleckchem.com/pr....oducts/ex229-compoun
Salivary vitamin-binding protein concentrations were not found to be indicative of systemic vitamin status.Enzalutamide, an antiandrogen, is approved for therapy of castration resistant prostate cancer. Clinical applications have shown that approximately 30% of patients acquire resistance after a short period of treatment. However, the molecular mechanisms underlying this resistance is not completely understood. To identify transcriptomic signatures associated with acquisition of drug resistance we profiled gene expression of
Like
Comment
Share
